Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19
Robert Rosales, Tim Janssen, Julia Yermash, Kimberly R. Yap, Elizabeth Ball, Bryan Hartzler, Bryan R. Garner, Sara J. Becker
Topics & Concepts
Harm reductionEthnic groupOpioid use disorderCoronavirus disease 2019 (COVID-19)PsychiatryHarm2019-20 coronavirus outbreakMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Opioid epidemicPsychologyClinical psychologyOpioidPublic healthSocial psychologyNursingSociologyVirologyInternal medicineDiseaseReceptorAnthropologyOutbreakInfectious disease (medical specialty)Opioid Use Disorder TreatmentHIV, Drug Use, Sexual RiskSubstance Abuse Treatment and Outcomes